Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Defensive stocks lead rebound in FTSE 100

Published 24/06/2022, 08:34
Updated 24/06/2022, 17:15
© Reuters. FILE PHOTO: A man shelters under an umbrella as he walks past the London Stock Exchange in London, Britain, August 24, 2015. REUTERS/Suzanne Plunkett/File Photo/File Photo

By Boleslaw Lasocki

(Reuters) -UK's FTSE 100 rose on Friday, lifted by defensive stocks at the end of a choppy week that saw investor anxiety over hawkish central banks, weak economic readings and heightened risks of a global recession.

The blue-chip index climbed 2.7%, with the biggest rises in healthcare and consumer staples stocks that tend to decouple from economic cycles.

The domestically focussed FTSE 250 rose 2.3%. Both the FTSE 100 and the mid-cap index snapped a three-week run of losses.

Data showed British retail sales volumes slid by 0.5% in May, showing that consumers cut back on shopping in the face of rapid inflation last month, and an increase in sales in April was revised down sharply.

Separate figures showed consumer confidence in the UK hit a record low this month.

"It is not just the rising bills of today that are worrying us, it is the prospect of even higher bills tomorrow, and fears of a looming recession, which might cause our finances to unravel entirely," Hargreaves Lansdown (LON:HRGV) analyst Sarah Coles said.

Adding to uncertainty, Boris Johnson's Conservatives lost two parliamentary seats on Friday, a crushing blow to the governing party that has intensified doubts about the future of Britain's prime minister.

Among stocks, Carnival Corp (LON:CCL) gained 8.7% after the cruise operator forecast a positive core profit for the current quarter, as it returns to full operations even as decades-high inflation and surging fuel costs continue to bite.[nL4N2YB2A2]

Ultra Electronics gained 12.3% after Britain moved forward on approving the acquisition of the defence firm by rival Cobham (LON:COB), after having raised security concerns over the planned transaction.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares of GSK rose 2.1% after French drugmaker Sanofi (EPA:SASY) said the vaccine against the Omicron variant of COVID-19, which the two companies worked on jointly, had proved effective.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.